Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Amenorrhea News and Headlines
Amenorrhea News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Amenorrhea
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Amenorrhea
.
Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Pharmalive.com:
similar ...
Primary Amenorrhea and PCOS Tied to Metabolic Syndrome
Medscape:
similar ...
TopAbstracts in Eating Disorders 07/01/2008
Doctors Guide:
similar ...
Bisphosphonates' Growing Role in Breast Cancer
Pharmacy Times:
similar ...
Low body weight 'key factor in assessing bone mineral density'
MedWire News:
similar ...
Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone
National Womens Health Information Center:
similar ...
Repros' Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
Business Wire:
similar ...
New findings in Cushing syndrome therapy described from Yonsei University
Health & Medicine Week via NewsRx.com:
similar ...
Biotech News: Shareholders alert for Columbia Laboratories Inc
M2 Communications Ltd.:
similar ...
Biotech News: Current Research on Columbia Laboratories Inc
M2 Communications Ltd.:
similar ...
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Business Wire:
similar ...
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Business Wire:
similar ...
Progesterone Gel
Business Wire:
similar ...
Wyeth Presents Data on a Tissue Selective Estrogen Complex Class for Menopausal Therapy
PR Newswire:
similar ...
Columbia Laboratories Comments on FDA Decision on Adeza's Gestiva
Business Wire:
similar ...
Columbia Laboratories Comments on FDA Reproductive Drugs Advisory Committee Recommendation on 17-OHPC; PROCHIEVE 8% Currently in Phase III Clinical Trial for Prevention of Recurrent Preterm Birth
Business Wire:
similar ...
Columbia Laboratories Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
Business Wire:
similar ...
Premature ovarian failure may be associated with genetic variants of human
Genomics & Genetics Weekly via NewsRx.com:
similar ...
Columbia Laboratories Added to NASDAQ Biotechnology Index
Business Wire:
similar ...
Researchers' data advance stem cell transplantation research
Pain & Central Nervous System Week via NewsRx.com:
similar ...
